- All sections
- C - Chemistry; metallurgy
- C07K - Peptides
- C07K 16/30 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Patent holdings for IPC class C07K 16/30
Total number of patents in this class: 10456
10-year publication summary
556
|
866
|
1039
|
1084
|
1097
|
1131
|
1054
|
1074
|
896
|
308
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Immatics Biotechnologies GmbH | 1144 |
408 |
Genentech, Inc. | 3742 |
192 |
F. Hoffmann-La Roche AG | 7958 |
147 |
The Regents of the University of California | 18943 |
137 |
Hoffmann-La Roche Inc. | 3060 |
134 |
The United States of America, as represented by the Secretary, Department of Health and Human Services | 2737 |
125 |
Regeneron Pharmaceuticals, Inc. | 3650 |
121 |
Memorial Sloan-Kettering Cancer Center | 1789 |
118 |
The Trustees of the University of Pennsylvania | 4122 |
105 |
Amgen Inc. | 3779 |
99 |
Chugai Seiyaku Kabushiki Kaisha | 1259 |
98 |
Immunomedics, Inc. | 290 |
91 |
Janssen Biotech, Inc. | 1347 |
85 |
Novartis AG | 11238 |
82 |
The Board of Trustees of the Leland Stanford Junior University | 6054 |
82 |
Amgen Research (Munich) GmbH | 236 |
81 |
SeaGen Inc | 554 |
81 |
Toray Industries, Inc. | 6652 |
71 |
Dana-Farber Cancer Institute, Inc. | 2455 |
71 |
Board of Regents, The University of Texas System | 5370 |
69 |
Other owners | 8059 |